Processes applied in our Clinic in the course of High Risk Pregnancy Follow-up:

Trimester Combined Screening Test (double test): In this test, risk is calculated according to mother’s age, fetal NT (Nuchal Translucency) measurement and b Hcg and Papp-A hormones in mother’s blood in order to detect pregnancies under high risk in terms of Down syndrome and some other chromosomal abnormalities. In patients with high fetal NT measurement results, the incidence of cardiac anomalies increases. This test is suggested to be conducted between 11-13+6 pregnancy weeks.

Trimester Screening Test (quadruple screening test): Used in detection of pregnancies bearing a high risk in terms of down syndrome and some other chromosomal anomalies and backbone defects (spina bifida). It is suggested to be conducted between 16th and 18th pregnancy weeks.

Level Ultrasonography (Detailed Ultrasonography): All organs of fetus are examined by ultrasonography in order to check ultrasonography indicators for congenital abnormalities and chromosomal abnormalities.

4D (4-dimensional) Ultrasonography: Face and external organs of fetus are viewed as 4-dimensional and colored.

Obstetric Color Doppler Ultrasonography: Makes measurements in blood vessels of mother and fetus, and gives information about baby’s blood flow and oxygenization. Some invasive processes are required for diagnosis of chromosomal anomalies, genetic diseases, congenital infections, etc.

Amniocentesis: A needle is inserted through the mother’s abdominal wall into uterus, and a small amount of amniotic fluid is sampled from amnion or amniotic sac surrounding the fetus.

CVS (Chronic villus sampling): A needle is inserted through the mother’s abdominal wall into uterus, and the developing placenta of fetus (chorionic villus) is sampled.